Eurofins is able supporting act on science double bill
Eurofins Scientific and Thermo Fisher Scientific both held investor update calls on Monday — and both announced deals on Tuesday. The science double bill proved no horror story, though, with investors clamouring for unrated Eurofins as well as Thermo Fisher’s jumbo multi-tranche deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts